Medicus Pharma (MDCX) President/CFO Carolyn Bonner Receives Award & Option

What Happened Carolyn F. Bonner, President and Chief Financial Officer of Medicus Pharma Ltd. (MDCX), received an equity award of 1,470,588 shares at $0.17 per share (total value reported as $250,735) and a 250,000-share derivative equity grant on September 4, 2026. The award is classified as a grant/award (A) rather than an open-market purchase or sale.

Key Details

• Transaction date: September 4, 2026; Form filed September 8, 2026 (four days after the transaction).
• Awarded shares: 1,470,588 shares at $0.17 per share — reported value $250,735.
• Derivative/option: 250,000 shares listed at $0.00 (no purchase price reported for the grant).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: F1 — the 250,000-share option was granted on Sept 4, 2026 and is scheduled to vest quarterly in four equal installments over one year.
• Timeliness: filing occurred four days after the transaction; Form 4s are generally required within two business days, so this appears to be a late filing.

Context

• These entries are grants/compensation awards (not open-market buys or sales) and are commonly part of executive pay programs. The 250,000-share item appears to be an option-like grant that vests over one year; there is no indication the shares were sold or that any cashless exercise occurred.